Treatment Of Coronary Artery Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Coronary Artery Disease stocks.

Treatment Of Coronary Artery Disease Stocks Recent News

Date Stock Title
May 2 BSX DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
May 2 BSX Zimmer Biomet (ZBH) Q1 Earnings Beat, Margins Expand
May 2 BSX Envista (NVST) Q1 Earnings Miss Estimates, Margins Down
May 2 BSX Reasons to Retain Quest Diagnostics (DGX) Stock for Now
May 2 BSX Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
May 2 BSX Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
May 2 BSX BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised
May 2 BSX Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts
May 2 BSX Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y
May 1 BSX Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up
May 1 BSX CVS Health's (CVS) Q1 Earnings Miss Estimates, Margins Up
May 1 BSX Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises
May 1 BSX Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised
Apr 30 BSX Boston Scientific Shares Tracking Higher
Apr 30 BSX Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
Apr 30 BSX QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand
Apr 30 OBIO Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
Apr 30 OBIO Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
Apr 29 BSX Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
Apr 29 BSX Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
Treatment Of Coronary Artery Disease

Browse All Tags